US Broker Ratings

MiMedx Group, Inc (MDXG) Stock Analysis: A Promising 70% Upside Potential in the Biotechnology Sector

MiMedx Group, Inc (NASDAQ: MDXG), a key player in the biotechnology sector, has been capturing the attention of investors with its recent financial performance and the..

Mesoblast Limited (MESO): Investor Outlook Reveals 85% Potential Upside Amidst Robust Revenue Growth

Mesoblast Limited (NASDAQ: MESO), a prominent player in the biotechnology sector, is capturing investor attention with a substantial potential upside of 85.57%. As a company deeply..

Amicus Therapeutics, Inc. (FOLD): Investor Outlook with 101% Potential Upside

Amicus Therapeutics, Inc. (NASDAQ: FOLD) stands as a promising player in the biotechnology sector, poised for significant growth. With a market capitalization of $2.46 billion, this..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Insights on a 16% Potential Upside for Investors

For investors eyeing opportunities in the healthcare sector, Alphatec Holdings, Inc. (NASDAQ: ATEC) presents a compelling case with a promising 16% potential upside. As a dynamic..

Opko Health, Inc. (OPK) Stock Analysis: A 155% Upside Potential Amidst a Challenging Landscape

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing case for investors. Despite..

Kymera Therapeutics (KYMR) Stock Analysis: Biotech Innovator Poised for 39.55% Upside

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a prominent player in the biotechnology sector, has recently captured the attention of investors with its ambitious approach to drug development...

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Navigating Healthcare with Innovative Solutions Amid Potential Downside

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a prominent player in the healthcare sector, specifically within the medical care facilities industry, has carved a niche for itself..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Exploring a 262% Potential Upside in Biotech Innovations

Viking Therapeutics, Inc. (VKTX), a prominent player in the biopharmaceutical landscape, presents a compelling investment opportunity within the burgeoning biotechnology sector. With a market capitalization of..

Denali Therapeutics (DNLI): Unveiling a 103% Potential Upside in Biotech Innovation

Denali Therapeutics Inc. (NASDAQ: DNLI), a trailblazing entity in the biotechnology sector, is capturing significant interest from investors with a remarkable potential upside of over 103%...

Azenta, Inc. (AZTA) Investor Outlook: Navigating a 11.98% Potential Upside Amidst Market Challenges

Azenta, Inc. (NASDAQ: AZTA), a key player in the Healthcare sector, specifically within the Medical Instruments & Supplies industry, is capturing investor attention with its innovative..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Revealing a 11.64% Potential Upside in a Competitive Market

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring the 50.24% Upside Potential

LifeStance Health Group, Inc. (LFST) is emerging as a compelling player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 17.70% Upside Potential

Alignment Healthcare, Inc. (NASDAQ: ALHC), a burgeoning player in the healthcare sector, is capturing investor interest with its robust growth potential and strategic positioning within the..

Innoviva, Inc. (INVA) Stock Analysis: Exploring a Potential 100% Upside

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, has been capturing investor attention with its robust growth potential and strategic partnerships. With a..

Structure Therapeutics Inc. (GPCR) Investor Outlook: Unpacking a 250% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR) is gaining significant traction among investors, and for good reason. With a market capitalization of $1.2 billion, this healthcare player is..

Omnicell, Inc. (OMCL) Stock Analysis: Healthcare Innovator Offers 36% Potential Upside

Omnicell, Inc. (OMCL), a prominent player in the healthcare sector specializing in health information services, is drawing attention with a notable potential upside of 36.10%. With..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Terrain with a 23% Downside Potential

Galapagos NV (GLPG), a prominent player in the biotechnology sector, is headquartered in Mechelen, Belgium, and focuses on developing innovative medicines in oncology and immunology across..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Potential 50% Upside in the Healthcare Sector

For investors keen on the healthcare sector, Kestra Medical Technologies, Ltd. (KMTS) represents a compelling opportunity, especially given its innovative approach to cardiovascular health. As a..

Organon & Co. (OGN) Stock Analysis: Navigating a 25.76% Potential Upside Amidst Market Challenges

Organon & Co. (NYSE: OGN) is a healthcare company that develops and delivers a diverse range of prescription therapies and medical devices globally. With a market..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Strong Revenue Growth and Analyst Consensus Points to Promising Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is emerging as a noteworthy player in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds